IMVT EBITDA Growth
Immunovant Inc · EBITDA Growth
IMVT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-20.97%period ending
IMVT TTM EBITDA YoY % (-259.47% → -20.97%)
Year-over-year change
High-resolution chart · PNG
IMVT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -20.9689% | |
| -22.3982% | |
| -20.505% | |
| -43.2917% | |
| -63.8859% | |
| -59.5792% | |
| -56.5658% | |
| -26.3429% | |
| -11.0187% | |
| -22.6706% | |
| -23.4649% | |
| -44.9266% | |
| -47.2364% | |
| -34.5081% | |
| -43.3903% | |
| -37.5433% | |
| -49.3314% | |
| -45.93% | |
| -38.089% | |
| -62.1531% | |
| -90.5195% | |
| -236.3669% | |
| -781.4718% | |
| -741.5506% | |
| -551.3618% | |
| -259.4724% |